Patterns of Treatment and Outcomes in Epithelial Ovarian Cancer: A Retrospective North Indian Single-Institution Experience

被引:5
作者
Meena, Rajendra Kumar [1 ]
Syed, Nisar Ahmad [1 ]
Sheikh, Zahoor Ahmad [2 ]
Guru, Faisal Rashid [1 ]
Mir, Mohmad Hussain [1 ]
Banday, Saquib Zaffar [1 ]
Krishnan, Arun [1 ]
Parveen, Shaheena [3 ]
Dar, Nazir Ahmad [4 ]
Bhat, Gull Mohammad [1 ]
机构
[1] Sher I Kashmir Inst Med Sci SKIMS, Dept Med Oncol, Srinagar, India
[2] Sher I Kashmir Inst Med Sci SKIMS, Dept Surg Oncol, Srinagar, India
[3] Sher I Kashmir Inst Med Sci SKIMS, Dept Gastroentrol, Srinagar, India
[4] Sher I Kashmir Inst Med Sci SKIMS, Dept Radiat Oncol, Srinagar, India
关键词
INTERVAL DEBULKING SURGERY; NEOADJUVANT CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; FALLOPIAN-TUBE; PERITONEAL; SURVIVAL; CARE; EPIDEMIOLOGY; CARCINOMA;
D O I
10.1200/GO.22.00032
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSEOvarian cancer (OC) is ranked as the third most common gynecologic cancer in various Indian cancer registries. In India, OC is seen in the younger age group, with a median age < 55 years being reported by most of the studies. The majority of patients are diagnosed in advanced stage (70%-80%), where the long-term (10-year) survival rate is poor, estimated at 15%-30%. The aim of this study was to evaluate clinical epidemiology, treatment patterns, and survival outcomes in patients with epithelial OC. METHODS This was a retrospective analysis of patients with epithelial OC who were treated at Sher-i-Kashmir Institute of Medical Sciences, Srinagar, over a period of 9 years, from January 2010 to December 2018. RESULTS OC constituted 2.94% of all cancers registered. Epithelial OC constituted 88.4% of all OCs, with a median age 50 years. More than two third of patients belonged to rural background and the majority (76.9%) of the patients were in stage III or IV at the time of diagnosis. The main presenting symptoms were abdominal distension/bloating (46.5%) and gastrointestinal disturbances (35.2%). The most common histologic types were serous (65.9%) followed by mucinous carcinoma (15%). Median overall survival for the whole study cohort was 30 months (95% CI, 28.0 to 31.9). Median overall survival for stage I, II, III, and IV was 72, 60, 30, and 20 months, respectively. CONCLUSION Most of the patients presented in advanced stage of the disease and have poor outcome. Delay in diagnosis and improper management before registering in tertiary cancer center and lack of tertiary care facilities are the root causes of poor outcomes. The general population and primary care physicians need to be made aware of OC symptoms.
引用
收藏
页数:8
相关论文
共 33 条
  • [1] [Anonymous], 2017, MED J DR PATIL U
  • [2] Basu P., 2009, Indian Journal of Cancer, V46, P28, DOI 10.4103/0019-509X.48592
  • [3] Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis
    Bristow, RE
    Tomacruz, RS
    Armstrong, DK
    Trimble, EL
    Montz, FJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) : 1248 - 1259
  • [4] Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients
    Earle, CC
    Schrag, D
    Neville, BA
    Yabroff, KR
    Topor, M
    Fahey, A
    Trimble, EL
    Bodurka, DC
    Bristow, RE
    Carney, M
    Warren, JL
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (03) : 172 - 180
  • [5] Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma
    Engelen, MJA
    Kos, HE
    Willemse, PHB
    Aalders, JG
    de Vries, EGE
    Schaapveld, M
    Otter, R
    van der Zee, AGJ
    [J]. CANCER, 2006, 106 (03) : 589 - 598
  • [6] Ezzati Mohammad, 2014, Int Sch Res Notices, V2014, P953509, DOI 10.1155/2014/953509
  • [7] Gajjar Ketan, 2012, ISRN Obstet Gynecol, V2012, P754197, DOI 10.5402/2012/754197
  • [8] Who should operate on patients with ovarian cancer? An evidence-based review
    Giede, KC
    Kieser, K
    Dodge, J
    Rosen, B
    [J]. GYNECOLOGIC ONCOLOGY, 2005, 99 (02) : 447 - 461
  • [9] Incidence of Ovarian, Peritoneal, and Fallopian Tube Carcinomas in the United States, 1995-2004
    Goodman, Marc T.
    Shvetsov, Yurii B.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (01) : 132 - 139
  • [10] CYTOREDUCTIVE SURGERY IN OVARIAN-CARCINOMA - FEASIBILITY AND MORBIDITY
    HEINTZ, APM
    HACKER, NF
    BEREK, JS
    ROSE, TP
    MUNOZ, AK
    LAGASSE, LD
    [J]. OBSTETRICS AND GYNECOLOGY, 1986, 67 (06) : 783 - 788